This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xia, L. Articles by Elder, J. T. Search for Related Content PubMed PubMed Citation Articles by Xia, L. Articles by Elder, J. T.

CaN19 Expression in Benign and Malignant Hyperplasias of the Skin and Oral Mucosa: Evidence for a Role in Regenerative Differentiation¹

Departments of Dermatology [L. X., S. W. S., T. M. J., J. T. E.], Surgery [M. L., T. M. J.], Radiation Oncology [S. P. E., J. T. E.], and Otorhinolaryngology [T. C., R. E., W. C., T. M. J.], University of Michigan Medical Center, and Veterans Affairs Medical Center [J. T. E.], Ann Arbor, Michigan 48109

CaN19, a member of the S100 family of calcium-binding proteins, is known to be "underexpressed" in cultured breast carcinoma-derived cell lines relative to their normal counterparts. By Northern blotting, we confirm these results and find that CaN19 is also markedly "underexpressed" in several carcinoma-derived cell lines of the skin, oral mucosa, and urogenital tract. However, exceptions to the inverse correlation between CaN19 expression and malignancy have been identified, bringing into question the hypothesis that CaN19 functions as a tumor suppressor gene. Unexpectedly, CaN19 mRNA was strongly expressed in bulk specimens of basal and squamous cell carcinomas of the skin and oral cavity. However, in situ hybridization revealed only limited CaN19 expression in tumor cells themselves; the bulk of expression is localized to hyperplastic perilesional epidermis. Tumor cell expression of CaN19 was similar in primary and locally metastatic tumors, indicating that this gene is not necessarily down-regulated during tumor progression. Coordinate overexpression of CaN19 and the "hyperproliferative" keratin K6a was observed only in tissues undergoing squamous differentiation. Taken together with other recent results from our laboratory, these findings suggest the hypothesis that CaN19 participates in an epidermal growth factor receptor-dependent pathway of regenerative squamous differentiation.

¹ This work was supported by awards from Veterans Affairs (to J. T. E.) and the Babcock Memorial Trust and by a grant from the Veterans Affairs Merit Review, Grants R29 AR40016 and R01 AR42248 from the National Institutes of Arthritis, Musculoskeletal, and Skin Diseases, and a grant from the Dermatology Foundation.

² To whom requests for reprints should be addressed, at Department of Dermatology, C560A MSRB II, Box 0672, University of Michigan, Ann Arbor, MI. Phone: (313) 763-0355; Fax: (313) 763-0355; E-mail: jelder@umich.edu.

Received 1/21/97. Accepted 5/15/97.

This article has been cited by other articles:

				L. Rittie, S. Kansra, S. W. Stoll, Y. Li, J. E. Gudjonsson, Y. Shao, L. E. Michael, G. J. Fisher, T. M. Johnson, and J. T. Elder Differential ErbB1 Signaling in Squamous Cell versus Basal Cell Carcinoma of the Skin Am. J. Pathol., June 1, 2007; 170(6): 2089 - 2099. [Abstract] [Full Text] [PDF]

				W.-C. Tsai, S.-T. Tsai, Y.-T. Jin, and L.-W. Wu Cyclooxygenase-2 Is Involved in S100A2-Mediated Tumor Suppression in Squamous Cell Carcinoma Mol. Cancer Res., August 1, 2006; 4(8): 539 - 547. [Abstract] [Full Text] [PDF]

				K. Hibi, S.-i. Fujitake, T. Takase, Y. Kodera, K. Ito, S. Akiyama, M. Shirane, and A. Nakao Identification of S100A2 as a Target of the {Delta}Np63 Oncogenic Pathway Clin. Cancer Res., September 15, 2003; 9(11): 4282 - 4285. [Abstract] [Full Text] [PDF]

				A.-M. Broome, D. Ryan, and R. L. Eckert S100 Protein Subcellular Localization During Epidermal Differentiation and Psoriasis J. Histochem. Cytochem., May 1, 2003; 51(5): 675 - 685. [Abstract] [Full Text] [PDF]

				G. Fontemaggi, I. Kela, N. Amariglio, G. Rechavi, J. Krishnamurthy, S. Strano, A. Sacchi, D. Givol, and G. Blandino Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses J. Biol. Chem., November 1, 2002; 277(45): 43359 - 43368. [Abstract] [Full Text] [PDF]

				G. Feng, X.-c. Xu, E. M. Youssef, and R. Lotan Diminished Expression of S100A2, a Putative Tumor Suppressor, at Early Stage of Human Lung Carcinogenesis Cancer Res., November 1, 2001; 61(21): 7999 - 8004. [Abstract] [Full Text] [PDF]